NCI advocates use of adjuvant therapy for rectal cancer.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D009316:National Institutes of Health (U.S.); D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012673:Semustine / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States
D012673:Semustine; D005472:Fluorouracil